
In Kentucky, collaborative agreements must be reviewed by the APRN and the collaborating physician, but the statutes do not set a specific review interval. Both the CAPA-NS and the CAPA-CS require review by the parties12.
For a CAPA-CS, all relevant statutes and regulations governing APRN controlled-substance prescribing must be reviewed at the outset of the agreement3. Additionally, any changes to a CAPA-NS or CAPA-CS—such as a practice address update—must be reported to the Kentucky Board of Nursing within 30 days4.
While a specific agreement review frequency isn’t prescribed, CAPA-CS requires structured collaboration meetings: at least quarterly in the first year and at least biannually in the next three years, focused on reverse KASPER/PDMP review and documentation56.